TickerFactsScreenerDevelopers

REGENERON PHARMACEUTICALS, INC. (REGN) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2008: $34.86M2009: $97.32M2010: $99.69M2011: $57.22M2012: $49.34M2013: $156.32M2014: $333.01M2015: $677.93M2016: $511.90M2017: $272.60M2018: $383.10M2019: $429.60M2020: $614.60M2021: $551.90M2022: $590.10M2023: $718.60M2024: $755.90M2025: $898.40M$898.40M
2008Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$898.40M+18.9%
2024$755.90M+5.2%
2023$718.60M+21.8%
2022$590.10M+6.9%
2021$551.90M-10.2%
2020$614.60M+43.1%
2019$429.60M+12.1%
2018$383.10M+40.5%
2017$272.60M-46.7%
2016$511.90M-24.5%
2015$677.93M+103.6%
2014$333.01M+113.0%
2013$156.32M+216.8%
2012$49.34M-13.8%
2011$57.22M-42.6%
2010$99.69M+2.4%
2009$97.32M+179.2%
2008$34.86M—